(NYSE: BMY) Bristol Myers Squibb Co's forecast annual revenue growth rate of 2.19% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 2.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.31%.
Bristol Myers Squibb Co's revenue in 2023 is $46,738,000,000.On average, 6 Wall Street analysts forecast BMY's revenue for 2023 to be $101,517,248,674,283, with the lowest BMY revenue forecast at $100,689,829,987,484, and the highest BMY revenue forecast at $102,639,051,270,406. On average, 6 Wall Street analysts forecast BMY's revenue for 2024 to be $103,657,864,785,482, with the lowest BMY revenue forecast at $100,284,692,259,523, and the highest BMY revenue forecast at $105,695,470,554,029.
In 2025, BMY is forecast to generate $106,132,111,599,851 in revenue, with the lowest revenue forecast at $104,666,621,562,116 and the highest revenue forecast at $108,742,045,715,246.